These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 241614)

  • 1. Metabolic activation of norethisterone (norethindrone) to an irreversibly protein-bound derivative by rat liver microsomes.
    Kappus H; Remmer H
    Drug Metab Dispos; 1975; 3(5):338-44. PubMed ID: 241614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irreversible protein binding of norethisterone (norethindrone) epoxide.
    Kappus H; Bolt HM
    Steroids; 1976 Jan; 27(1):29-45. PubMed ID: 4905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of 14C-toluene to covalently binding metabolites by rat liver microsomes.
    Pathiratne A; Puyear RL; Brammer JD
    Drug Metab Dispos; 1986; 14(4):386-91. PubMed ID: 2873983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practolol metabolism. III. Irreversible binding of [14C]practolol metabolite(s) to mammalian liver microsomes.
    Orton TC; Lowery C
    J Pharmacol Exp Ther; 1981 Oct; 219(1):207-12. PubMed ID: 6793710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.
    Marinello AJ; Bansal SK; Paul B; Koser PL; Love J; Struck RF; Gurtoo HL
    Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference.
    Woolf TF; Pool WF; Bjorge SM; Chang T; Goel OP; Purchase CF; Schroeder MC; Kunze KL; Trager WF
    Drug Metab Dispos; 1993; 21(5):874-82. PubMed ID: 7902251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P-450 dependent irreversible binding of 6-thiopurine to rat liver microsomal protein in vitro and protection by glutathione.
    Hyslop RM; Jardine I
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):163-73. PubMed ID: 31662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of haloforms to carbon monoxide. I. In vitro studies.
    Ahmed AE; Kubic VL; Anders MW
    Drug Metab Dispos; 1977; 5(2):198-204. PubMed ID: 15814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the NADPH-dependent covalent binding of [14C]halothane to human liver microsomes: a role for cytochrome P4502E1 at low substrate concentrations.
    Madan A; Parkinson A
    Drug Metab Dispos; 1996 Dec; 24(12):1307-13. PubMed ID: 8971135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monooxygenase-mediated activation of chlorotrianisene (TACE) in covalent binding to rat hepatic microsomal proteins.
    Juedes MJ; Bulger WH; Kupfer D
    Drug Metab Dispos; 1987; 15(6):786-93. PubMed ID: 2893703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic activation of model pyrroles by cytochrome P-450.
    Guengerich FP; Mitchell MB
    Drug Metab Dispos; 1980; 8(1):34-8. PubMed ID: 6102027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of methimazole by rat liver cytochrome P-450-containing monoxygenases.
    Lee PW; Neal RA
    Drug Metab Dispos; 1978; 6(5):591-600. PubMed ID: 30610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism for isaxonine hepatitis. I. Metabolic activation by mouse and human cytochrome P-450.
    Lettéron P; Fouin-Fortunet H; Tinel M; Danan G; Belghiti J; Pessayre D
    J Pharmacol Exp Ther; 1984 Jun; 229(3):845-50. PubMed ID: 6547179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covalent binding of a reactive metabolite derived from propranolol and its active metabolite 4-hydroxypropranolol to hepatic microsomal proteins of the rat.
    Narimatsu S; Arai T; Watanabe T; Masubuchi Y; Horie T; Suzuki T; Ishikawa T; Tsutsui M; Kumagai Y; Cho AK
    Chem Res Toxicol; 1997 Mar; 10(3):289-95. PubMed ID: 9084908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme-mediated covalent binding of hydralazine to rat liver microsomes.
    Streeter AJ; Timbrell JA
    Drug Metab Dispos; 1983; 11(3):179-83. PubMed ID: 6135572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment.
    Hissink AM; Oudshoorn MJ; Van Ommen B; Haenen GR; Van Bladeren PJ
    Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cytochrome P-450IIB1 as a cocaine-bioactivating isoform in rat hepatic microsomes and in cultured rat hepatocytes.
    Boelsterli UA; Lanzotti A; Göldlin C; Oertle M
    Drug Metab Dispos; 1992; 20(1):96-101. PubMed ID: 1347004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro studies on the metabolic activation of the furanopyridine L-754,394, a highly potent and selective mechanism-based inhibitor of cytochrome P450 3A4.
    Sahali-Sahly Y; Balani SK; Lin JH; Baillie TA
    Chem Res Toxicol; 1996 Sep; 9(6):1007-12. PubMed ID: 8870989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interaction of acrylates with the microsomal oxidation system in the rat liver].
    Kotlovskiĭ IuV; Bekerev VE; Bachmanova GI; Ivanov VV
    Vopr Med Khim; 1985; 31(6):74-7. PubMed ID: 4090391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denitrosation of the anti-cancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea catalyzed by microsomal glutathione S-transferase and cytochrome P450 monooxygenases.
    Weber GF; Waxman DJ
    Arch Biochem Biophys; 1993 Dec; 307(2):369-78. PubMed ID: 8274024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.